Skip to main content
Premium Trial:

Request an Annual Quote

KeyGene Licenses Sequence-Based Genotyping Tech to University of Wisconsin

NEW YORK (GenomeWeb) – KeyGene announced today that it has licensed its proprietary sequence-based genotyping (SBG) technology to the University of Wisconsin-Madison.

The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment. Under the terms of the deal, UW-Madison will be able to offer SBG services in all species to its research collaborators and clients worldwide. Additional terms were not disclosed.

The UW Biotechnology Center will "offer services under KeyGene’s SBG patents to its partners and collaborators to advance our understanding of genetic variation in crops, animals, and model species," Joshua Hyman, director of the center's DNA sequencing facility, said in a statement.

KeyGene has licensed the SBG technology to a number of organizations including the University of Minnesota, LGC, Bayer, and Floragenex.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.